Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from SYNH

Markets Today: Stocks Rally as U.S. CPI Eases

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are up +0.37%, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.45%. U.S. stock index futures this morning erased overnight losses and pushed higher after U.S. consumer prices eased in April. Bond yields also fell on the...

Barchart · May 10, 2023

Syneos Health's Return On Capital Employed Insights

Pulled from Benzinga Pro data, Syneos Health (NASDAQ:SYNH) posted Q1 earnings of $46.18 million, an increase from Q4 of 39.21%. Sales dropped to $1.34 billion, a 2.69% decrease between quarters.

Benzinga · May 6, 2022

Syneos Health Shares Jump On Better Than Expected Q1 Earnings, FY22 Outlook

Syneos Health Inc's (NASDAQ:SYNH) Q1 revenue increased 10.5% on a reported basis and 11.7% on a constant currency (CC) basis to $1.34 billion, beating the consensus of $1.32 billion. Clinical Solutions revenue increased 8.4% (+9.6% CC) to $1.02 billion. Acquisitions contributed approximately 1,00 basis points to Clinical Solutions' reported revenue growth. Commercial Solutions…

Benzinga · Apr 29, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Syneos Health: Q1 Earnings Insights

Syneos Health (NASDAQ:SYNH) reported its Q1 earnings results on Friday, April 29, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Benzinga · Apr 29, 2022

Looking Into Syneos Health's Return On Capital Employed

Pulled from Benzinga Pro data, Syneos Health (NASDAQ:SYNH) showed a loss in earnings since Q3, totaling $75.96 million. Sales, on the other hand, increased by 1.84% to $1.37 billion during Q4.

Benzinga · Feb 18, 2022

Syneos Health Reports Mixed Q4 Earnings, Provides FY22 Guidance

Syneos Health Inc's (NASDAQ: SYNH) Q4 revenue increased 20.5% on a reported basis and 20.8% on a constant currency (CC) basis to

Benzinga · Feb 17, 2022

Analyst Ratings For Syneos Health

Within the last quarter, Syneos Health (NASDAQ:SYNH) has observed the following analyst ratings:

Benzinga · Jan 27, 2022

Read news from The Economist, FT, and more,
with one subscription

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

United States

423,634 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.